Literature DB >> 12595485

Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae.

Maeya Ngamying1, Pathom Sawanpanyalert, Raywadee Butraporn, Junjira Nikasri, Sang-Nae Cho, Louis Levy, Patrick J Brennan.   

Abstract

Only native products of Mycobacterium leprae, whether cell wall, cytosol, or membrane derived, can confer protective immunity against challenge in the mouse footpad. Previously, recombinant proteins were shown to be ineffective. The cell wall skeleton-the mycolyl-arabinogalactan-peptidoglycan complex-devoid of proteins is not protective.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12595485      PMCID： PMC148868          DOI： 10.1128/IAI.71.3.1596-1598.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  27 in total

1.  Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.

Authors:  J Convit; C Sampson; M Zúñiga; P G Smith; J Plata; J Silva; J Molina; M E Pinardi; B R Bloom; A Salgado
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

2.  Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

Authors:  E M Beckman; S A Porcelli; C T Morita; S M Behar; S T Furlong; M B Brenner
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

3.  Global case-detection trend in leprosy.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-06-13

4.  A comparison of the effectiveness of two freeze-dried BCG vaccines against Mycobacterium leprae in mice.

Authors:  C C Shepard
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  Cell walls from Mycobacterium tuberculosis (BCG) as vaccine against Mycobacterium leprae infections in mice.

Authors:  C C Shepard; E Ribi
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

6.  Comparative leprosy vaccine trial in south India.

Authors:  M D Gupte; R S Vallishayee; D S Anantharaman; B Nagaraju; S Balasubramanyam; R L de Britto; N Elango; N Uthayakumaran; V N Mahalingam; G Lourdusamy; A Ramalingam; S Kannan; J Arokiasamy
Journal:  Indian J Lepr       Date:  1998 Oct-Dec

7.  Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice.

Authors:  A Campos-Neto; J R Webb; K Greeson; R N Coler; Y A W Skeiky; S G Reed
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  CD1-restricted T cell recognition of microbial lipoglycan antigens.

Authors:  P A Sieling; D Chatterjee; S A Porcelli; T I Prigozy; R J Mazzaccaro; T Soriano; B R Bloom; M B Brenner; M Kronenberg; P J Brennan
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

Review 9.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.

Authors:  R H Gelber; V Mehra; B Bloom; L P Murray; P Siu; M Tsang; P J Brennan
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441
View more
  7 in total

Review 1.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

Review 2.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Pathogenesis and Host Immune Response in Leprosy.

Authors:  Hadida Yasmin; Praveen Mathews Varghese; Sanjib Bhakta; Uday Kishore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Antigen-specific T-cell responses of leprosy patients.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Lucas H Sampaio; A B Grassi; Ana Lucia M Sousa; Celina M T Martelli; Mariane M A Stefani; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

5.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

6.  Inhibition of the multiplication of Mycobacterium leprae by vaccination with a recombinant M. bovis BCG strain that secretes major membrane protein II in mice.

Authors:  Y Maeda; T Tamura; M Matsuoka; M Makino
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

Review 7.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.